Qsam Biosciences Performance
| QSAMDelisted Stock | USD 4.49 0.05 1.13% |
The company holds a Beta of 1.32, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Qsam Biosciences will likely underperform. Qsam Biosciences right now holds a risk of 0.0%. Please check Qsam Biosciences treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Qsam Biosciences will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Qsam Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Qsam Biosciences is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 225.3 K | |
| Free Cash Flow | -2.8 M |
Qsam |
Qsam Biosciences Relative Risk vs. Return Landscape
If you would invest 449.00 in Qsam Biosciences on September 15, 2024 and sell it today you would earn a total of 0.00 from holding Qsam Biosciences or generate 0.0% return on investment over 90 days. Qsam Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Qsam, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Qsam Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Qsam Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Qsam Biosciences, and traders can use it to determine the average amount a Qsam Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| QSAM |
Based on monthly moving average Qsam Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Qsam Biosciences by adding Qsam Biosciences to a well-diversified portfolio.
Qsam Biosciences Fundamentals Growth
Qsam OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Qsam Biosciences, and Qsam Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Qsam OTC Stock performance.
| Return On Equity | -33.77 | |||
| Return On Asset | -2.38 | |||
| Current Valuation | 36.03 M | |||
| Shares Outstanding | 4.45 M | |||
| Price To Book | 201.64 X | |||
| Price To Sales | 1.71 X | |||
| EBITDA | (3.94 M) | |||
| Cash And Equivalents | 429.35 K | |||
| Cash Per Share | 0.25 X | |||
| Total Debt | 7.5 K | |||
| Debt To Equity | 2.08 % | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (2.85 M) | |||
| Earnings Per Share | (1.69) X | |||
| Total Asset | 1.71 M | |||
| Retained Earnings | (40.16 M) | |||
About Qsam Biosciences Performance
By examining Qsam Biosciences' fundamental ratios, stakeholders can obtain critical insights into Qsam Biosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Qsam Biosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. QSAM Biosciences, Inc. was incorporated in 2004 and is headquartered in Austin, Texas. Qsam Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.Things to note about Qsam Biosciences performance evaluation
Checking the ongoing alerts about Qsam Biosciences for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Qsam Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Qsam Biosciences is not yet fully synchronised with the market data | |
| Qsam Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Qsam Biosciences currently holds 7.5 K in liabilities with Debt to Equity (D/E) ratio of 2.08, implying the company greatly relies on financing operations through barrowing. Qsam Biosciences has a current ratio of 0.23, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Qsam Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Qsam Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Qsam Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Qsam to invest in growth at high rates of return. When we think about Qsam Biosciences' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (4.39 M) with profit before overhead, payroll, taxes, and interest of 916.67 K. | |
| Qsam Biosciences currently holds about 429.35 K in cash with (2.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.25. | |
| Roughly 52.0% of Qsam Biosciences outstanding shares are owned by corporate insiders |
- Analyzing Qsam Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Qsam Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Qsam Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Qsam Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Qsam Biosciences' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Qsam Biosciences' otc stock. These opinions can provide insight into Qsam Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation. Note that the Qsam Biosciences information on this page should be used as a complementary analysis to other Qsam Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Qsam OTC Stock
If you are still planning to invest in Qsam Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Qsam Biosciences' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |